Literature DB >> 28293905

Hyperphenylalaninemia Correlated with Global Decrease of Antioxidant Genes Expression in White Blood Cells of Adult Patients with Phenylketonuria.

Charlotte Veyrat-Durebex1,2, Christelle Debeissat3,4, Hélène Blasco5,6, Franck Patin5,6, Hélène Henique7,8, Patrick Emond6, Catherine Antar5,6, Valérie Gissot9, Olivier Herault3,4, François Maillot7,8.   

Abstract

BACKGROUND: Several studies have highlighted disturbance of redox homeostasis in patients with phenylketonuria (PKU) which may be associated with neurological disorders observed in patients, especially during adulthood when phenylalanine restrictive diets are not maintained. The aim of this study was to assess the antioxidant profile in a cohort of PKU patients in comparison to the controls and to evaluate its relation to biochemical parameters especially phenylalaninemia.
METHODS: We measured RNA expression of 22 antioxidant genes and reactive oxygen species (ROS) levels in white blood cells of 10 PKU patients and 10 age- and gender-matched controls. We also assessed plasma amino acids, vitamins, oligo-elements, and urinary organic acids concentrations. Then we evaluated the relationship between redox status and biochemical parameters.
RESULTS: In addition to expected biochemical disturbances, we highlighted a significant global decrease of antioxidant genes expression in PKU patients in comparison to the controls. This global decrease of antioxidant genes expression, including various isoforms of peroxiredoxins, glutaredoxins, glutathione peroxidases, and superoxide dismutases, was significantly correlated to hyperphenylalaninemia.
CONCLUSION: This study is the first to evaluate the expression of 22 antioxidant genes in white blood cells regarding biochemical parameters in PKU. These findings highlight the association of hyperphenylalaninemia with antioxidant genes expression. New experiments to specify the role of oxidative stress in PKU pathogenesis may be useful in suggesting new recommendations in PKU management and new therapeutic trials based on antioxidant defenses.

Entities:  

Keywords:  PKU; Phenylketonuria; RNA antioxidant profile; Redox status

Year:  2017        PMID: 28293905      PMCID: PMC5740050          DOI: 10.1007/8904_2017_16

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  57 in total

1.  Characterization of alpha-amino-n-butyric acid correlations in sepsis.

Authors:  Carlo Chiarla; Ivo Giovannini; John H Siegel
Journal:  Transl Res       Date:  2011-07-18       Impact factor: 7.012

Review 2.  Adult phenylketonuria outcome and management.

Authors:  F Trefz; F Maillot; K Motzfeldt; M Schwarz
Journal:  Mol Genet Metab       Date:  2011-08-26       Impact factor: 4.797

Review 3.  Phenylketonuria Pathophysiology: on the Role of Metabolic Alterations.

Authors:  Patrícia Fernanda Schuck; Fernanda Malgarin; José Henrique Cararo; Fabiola Cardoso; Emilio Luiz Streck; Gustavo Costa Ferreira
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

4.  Glutathione metabolism enzymes in brain and liver of hyperphenylalaninemic rats and the effect of lipoic acid treatment.

Authors:  Tarsila Barros Moraes; Giovana Reche Dalazen; Carlos Eduardo Jacques; Raylane Silva de Freitas; Andrea Pereira Rosa; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2014-02-02       Impact factor: 3.584

5.  Increased oxidative stress in patients with 3-hydroxy-3-methylglutaric aciduria.

Authors:  Mariana Dos Santos Mello; Graziela Schmitt Ribas; Carlos Alberto Yasin Wayhs; Tatiane Hammerschmidt; Gilian Batista Balbueno Guerreiro; Jéssica Lamberty Favenzani; Ângela Sitta; Daniella de Moura Coelho; Moacir Wajner; Carmen Regla Vargas
Journal:  Mol Cell Biochem       Date:  2015-01-04       Impact factor: 3.396

6.  A longitudinal study of antioxidant status in phenylketonuric patients.

Authors:  Rafael Artuch; Catrina Colomé; Cristina Sierra; Nuria Brandi; Nilo Lambruschini; Jaume Campistol; Dolores Ugarte; Maria A Vilaseca
Journal:  Clin Biochem       Date:  2004-03       Impact factor: 3.281

7.  Therapeutic brain modulation with targeted large neutral amino acid supplements in the Pah-enu2 phenylketonuria mouse model.

Authors:  Danique van Vliet; Vibeke M Bruinenberg; Priscila N Mazzola; Martijn Hjr van Faassen; Pim de Blaauw; Tiziana Pascucci; Stefano Puglisi-Allegra; Ido P Kema; M Rebecca Heiner-Fokkema; Eddy A van der Zee; Francjan J van Spronsen
Journal:  Am J Clin Nutr       Date:  2016-09-21       Impact factor: 7.045

8.  Glutathione peroxidase and glutathione S-transferase activity of platelets.

Authors:  H Menzel; G Steiner; I Lombeck; F K Ohnesorge
Journal:  Eur J Pediatr       Date:  1983 Jun-Jul       Impact factor: 3.183

9.  Antioxidant status in hyperphenylalaninemia.

Authors:  C Sierra; M A Vilaseca; D Moyano; N Brandi; J Campistol; N Lambruschini; F J Cambra; R Deulofeu; A Mira
Journal:  Clin Chim Acta       Date:  1998-08-10       Impact factor: 3.786

10.  Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man.

Authors:  W Krause; M Halminski; L McDonald; P Dembure; R Salvo; D Freides; L Elsas
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

View more
  3 in total

1.  Creatine plus pyruvate supplementation prevents oxidative stress and phosphotransfer network disturbances in the brain of rats subjected to chemically-induced phenylketonuria.

Authors:  Vanessa Trindade Bortoluzzi; Letícia Brust; Thales Preissler; Itiane Diehl de Franceschi; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2019-07-27       Impact factor: 3.584

Review 2.  Oxidative stress in phenylketonuria-evidence from human studies and animal models, and possible implications for redox signaling.

Authors:  Vanessa Trindade Bortoluzzi; Carlos Severo Dutra Filho; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2021-02-13       Impact factor: 3.584

3.  Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation.

Authors:  Claire Cannet; Andrea Pilotto; Júlio César Rocha; Hartmut Schäfer; Manfred Spraul; Daniela Berg; Peter Nawroth; Christian Kasperk; Gwendolyn Gramer; Dorothea Haas; David Piel; Stefan Kölker; Georg Hoffmann; Peter Freisinger; Friedrich Trefz
Journal:  Orphanet J Rare Dis       Date:  2020-02-27       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.